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This book contains papers presented at a Symposium held in Steamboat Springs, Colorado in April 1986. 
The meeting formed part of the UCLA Symposium series established 15 years ago to bring together e- 
searchers from different disciplines who are working in rapidly developing areas of basic or applied biology. 
The theme of this conference was the antiproliferative effects of the interferons and their potential for anti- 
cancer therapeutic applications. 
Although much is known about the mechanisms underlying the antiviral effects of the interferons, there 
is considerably less understanding of the molecular basis of the actions of interferons as 'negative growth 
factors'. This book, however, provides as up-to-date a summary of the current state of knowledge as can 
be expected to be found under a single cover. There are sections on gene regulation by interferons, im- 
munoregulation, the nature and role of interferon receptors on the cell surface, the relationship between 
interferons, growth factors and oncogene xpression, and in vivo antitumour effects in animal models and 
clinical situations. The whole work is prefaced by an Introduction by Peter Lengyel describing some areas 
of recent excitement in these fields. There is also a good, detailed index. 
As usual with such multi-author volumes as this one, which are prepared in camera-ready format, the 
quality of both the science and its clarity of presentation is variable. However, there are some gems to be 
found within the 42 separate research papers presented; interestingly, these are not always the articles with 
the greatest amounts of data included. Personally I found the most exciting work in the sections on regula- 
tion of gene expression and the control of oncogene activity by interferons. The description by Frances 
Balkwill of the antitumour effects of interferons in animal models also impressed, not least because it pro- 
vides a strong framework for the application of erudite molecular biology to a field which still holds poten- 
tial for the treatment of at least some forms of human cancer. 
A general impression which emerges from reading the book is the fact that the interferons are not just 
negative cytostatic or cytotoxic agents, but possess the ability to modulate gene expression in ways which 
markedly alter the cellular phenotype. Depending on the cell type, such alterations can lead to development 
of an antiviral state, inhibition of cell proliferation, promotion of cell differentiation, or activation of a 
variety of pathways which modulate functions of the immune system. Readers of this book can get a flavour 
of each of these areas where interferon treatment impinges on the biology of mammalian ceils. 
Mike Clemens 
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